Advisor Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Advisor Group’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$17K	Buy	875 +80	+10%	+$1.53K	﹤0.01%	4037
2019 Q3	$16K	Hold	795	–	–	﹤0.01%	4085
2019 Q2	$17K	Buy	795 +45	+6%	+$941	﹤0.01%	4061
2019 Q1	$15K	Sell	750 -750	-50%	-$16.8K	﹤0.01%	4124
2018 Q4	$30K	Hold	1,500	–	–	﹤0.01%	3525
2018 Q3	$29K	Sell	1,500 -1,000	-40%	-$17.8K	﹤0.01%	3644
2018 Q2	$38K	Buy	2,500 +900	+56%	+$15.7K	﹤0.01%	3298
2018 Q1	$30K	Hold	1,600	–	–	﹤0.01%	3417
2017 Q4	$31K	Hold	1,600	–	–	﹤0.01%	3409
2017 Q3	$29K	Sell	1,600 -264	-14%	-$4.34K	﹤0.01%	3335
2017 Q2	$34K	Buy	1,864 +1,797	+2,682%	+$28.5K	﹤0.01%	3110
2017 Q1	$1K	Buy	+67	New	+$1.05K	﹤0.01%	4494
2016 Q4	–	Sell	-487	Closed	-$9K	–	4490
2016 Q3	$9K	Buy	+487	New	+$8.84K	﹤0.01%	3599

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Group's AMPH Position: Q4 2019 in Review

Advisor Group increased its Amphastar Pharmaceuticals (AMPH) stake by 10% in Q4 2019, buying an estimated $1.53K and bringing the position to 875 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #4037.

Advisor Group first reported a position in AMPH in Q3 2016 and has held it in 13 quarters since. The position peaked at $38K in Q2 2018. 119 funds tracked by Wall St. Rank hold AMPH as of Q4 2019.

Advisor Group held 875 shares of Amphastar Pharmaceuticals worth $17K as of Q4 2019.
Advisor Group bought 80 Amphastar Pharmaceuticals shares in Q4 2019, an estimated $1.53K.
Amphastar Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4037 holding.
Advisor Group first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 13 quarters since.
Advisor Group's Amphastar Pharmaceuticals position peaked at $38K in Q2 2018.
119 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.